Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "patient safety"
Home
“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families
“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
09/21/2026, 21:59 ET
Exclusive: Non-Diabetic Woman, 84, Repeatedly Collapses After Pharmacy Dispenses Blood Sugar Drug by Mistake
“No one uses common sense and goes through three months’ worth of medication from a pharmacy, checking each individual packet to make sure it was...
09/21/2026, 21:44 ET
South Korea to Ban ‘AI Fake Doctors’ in Medical Device Ads Starting December
Starting this December, advertisements that use artificial intelligence to generate virtual figures resembling real...
09/21/2026, 21:44 ET
Does Wegovy Triple Depression Risk? Real-World Data from Korean Hospitals Yields Nuanced Findings
A recent observational study indicates that individuals taking popular GLP-1 receptor agonist obesity medications may...
09/15/2026, 10:34 ET
Sudden Cold Sweats and Blurred Vision: Why You Should Lie Down, Not Tough It Out
A sudden wave of nausea hits, cold sweat breaks out, vision blurs, ears feel plugged, and a profound weakness sweeps...
09/13/2026, 10:16 ET
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
09/13/2026, 09:58 ET
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
09/12/2026, 04:20 ET
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...
09/10/2026, 04:21 ET
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone
For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...
09/07/2026, 05:19 ET
4 Things Older Adults Must Check Before Getting Dental Implants
Concerns over the safety of dental implants for older adults are rising following a series of fatal incidents at a...
09/07/2026, 05:13 ET
Previous
3
4
5
6
7
Next